Publicación:
Nitazoxanide for treatment of intestinal parasites in children

dc.contributor.authorOchoa, Theresa J.
dc.contributor.authorWhite Jr., A. Clinton
dc.date.accessioned2026-05-14T14:28:15Z
dc.date.issued2005
dc.description.abstractNitazoxanide is an important new antiparasitic drug. It is effective for cryptosporidiosis in normal hosts, malnourished children and HIV patients with higher CD4 cell counts. Nitazoxanide is equivalent to metronidazole in giardiasis but may be better tolerated. It has wide spectrum activity against intestinal protozoan and helminth infections. Intestinal protozoa are important but underdiagnosed causes of persistent diarrhea in both developing and developed countries. Empiric therapy with nitazoxanide, which is effective, well-tolerated and modestly priced, may be a reasonable and more cost-effective alternative to pursuing specific diagnoses in selected populations. Copyright © 2005 by Lippincott Williams & Wilkins.en_US
dc.identifier.doihttps://doi.org/10.1097/01.inf.0000171522.79099.c5
dc.identifier.scopus2-s2.0-22244468741
dc.identifier.urihttps://hdl.handle.net/20.500.12866/19663
dc.language.isoeng
dc.publisherLippincott Williams and Wilkins
dc.relation.ispartofurn:issn:0891-3668
dc.relation.ispartofseriesPediatric Infectious Disease Journal
dc.relation.issn0891-3668
dc.rightshttp://purl.org/coar/access_right/c_14cb
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectDiarrheaen_US
dc.subjectNitazoxanideen_US
dc.subjectParasitesen_US
dc.titleNitazoxanide for treatment of intestinal parasites in childrenen_US
dc.typehttps://purl.org/coar/resource_type/c_2df8fbb1
dc.type.localArtículo de revista
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication

Archivos